Clinical Trials Sponsored by Shanghai Jiatan Pharmatech Co., Ltd

Total 1257 results

Shanghai Jiatan Pharmatech Co., Ltd

Completed

Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081 (WX-081)

Pulmonary Tuberculosis

China
Shanghai Jiatan Pharmatech Co., Ltd

Recruiting

A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors

Solid Tumor

China
Shanghai Jiatan Pharmatech Co., Ltd

Enrolling by invitation

Sudapyridine (WX-081) in RR/MDR/XDR-tuberculosis Patients (WISH)

Rifampicin-resistant Tuberculosis

China
Shanghai Jiatan Pharmatech Co., Ltd

Completed

A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations

PIK3CA Mutation-Related Tumors

China
Shanghai Jiatan Pharmatech Co., Ltd

Completed

A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma

Advanced Cancer

China
Shanghai Jiatan Pharmatech Co., Ltd

Recruiting

A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations

Gastric Type Adenocarcinoma (GAS) With STK11 Mutation

China
Shanghai Jiatan Pharmatech Co., Ltd

Recruiting

A Study of WX390 in Patients With Advanced Solid Tumors

Solid Tumor

China
Shanghai Jiatan Pharmatech Co., Ltd

Completed

Sudapyridine (WX-081) in Healthy Volunteers

Healthy

China
Shanghai De Novo Pharmatech Co., Ltd.

Completed

A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors

Advanced Solid Tumors

United States
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Shanghai De Novo Pharmatech Co., Ltd.

Unknown

Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers

Advanced Solid Tumors

China
Chengdu SciMount Pharmatech Co., Ltd.

Completed

3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability

Healthy Volunteers

Australia
Chengdu SciMount Pharmatech Co., Ltd.

Completed

A Phase 1 Study of SMP-100 in Normal Healthy Volunteers

Healthy Volunteers

Australia
Dong-A PharmTech Co., Ltd.

Completed

A Study of DA-8159 in Subjects With Erectile Dysfunction

Erectile Dysfunction

United States
Jiayuan Sun
Zhouling (Shanghai) Medical Appliance Co., Ltd.

Recruiting

Feasibility Study of the Pulsed Electric Field Ablation System in Treating Chronic Bronchitis

Chronic Bronchitis

China
InxMed (Shanghai) Co., Ltd.
InventisBio Co., Ltd

Recruiting

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

Solid Tumor

China
InventisBio Co., Ltd
InxMed (Shanghai) Co., Ltd.

Recruiting

Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors

Solid Tumor

China
Shanghai YingLi Pharmaceutical Co. Ltd.
Shanghai HyaMab Biotech Co.,Ltd.

Not yet recruiting

A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor

Advanced Solid Tumors
Shanghai SIMRD Biotechnology Co., Ltd.

Completed

The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers

Healthy

China
Shanghai SIMRD Biotechnology Co., Ltd.

Completed

The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers

Healthy

China
Convalife (Shanghai) Co., Ltd.

Not yet recruiting

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

Advanced Solid Tumors

China
InxMed (Shanghai) Co., Ltd.

Recruiting

IN10018 Combination Therapy in Treatment-naïve ES-SCLC

Small Cell Lung Cancer Extensive Stage

China
InxMed (Shanghai) Co., Ltd.

Recruiting

IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer

Pancreatic Cancer

China
Shanghai GeneChem Co., Ltd.

Unknown

A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia

Leukemia, B-Cell

China
InxMed (Shanghai) Co., Ltd.

Not yet recruiting

IN10018 Combination Therapy in Previously-treated Solid Tumors

Solid Tumor
InxMed (Shanghai) Co., Ltd.

Active, not recruiting

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

Locally Advanced or Metastatic Solid Tumors

China
Shanghai GeneChem Co., Ltd.

Unknown

A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma (meso-CART)

Pancreatic Cancer

China
Convalife (Shanghai) Co., Ltd.

Not yet recruiting

Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases

Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis
Convalife (Shanghai) Co., Ltd.

Not yet recruiting

CVL237 Tablets for APDS/PASLI

PI3K and P110delta Hyperactivation Syndrome

China
Convalife (Shanghai) Co., Ltd.

Not yet recruiting

Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations (CVL009-2001)

NSCLC

China
InxMed (Shanghai) Co., Ltd.

Recruiting

IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Ovarian Cancer Recurrent

China
InxMed (Shanghai) Co., Ltd.

Recruiting

IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC

NSCLC

China
InxMed (Shanghai) Co., Ltd.

Recruiting

IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer

Platinum-resistant Ovarian Cancer

China
InxMed (Shanghai) Co., Ltd.

Recruiting

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Metastatic Melanoma

United States, Australia
InxMed (Shanghai) Co., Ltd.

Completed

IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma

Gastric Cancer

China
Hepagene (Shanghai) Co., Ltd.

Active, not recruiting

Phase 2a Study of HPG1860 in Subjects With NASH (RISE)

NASH - Nonalcoholic Steatohepatitis

United States
Shanghai Cingularbio Co. Ltd

Completed

Cingularbio® Heart Valve Clincial Study

Diseases of Mitral and Aortic Valves

China, Belgium, Poland
Hepagene (Shanghai) Co., Ltd.

Completed

Study of Safety, Tolerability and PK, PD of HPG1860 in Healthy Subjects

Healthy

United States
Shanghai GeneChem Co., Ltd.

Unknown

A Study of GPC3 Redirected Autologous T Cells for Advanced HCC (GPC3-CART)

Carcinoma, Hepatocellular

China
Changhai Hospital
Shanghai Ultra-T Immune Therapeutics Co. LTD

Not yet recruiting

A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1-positive Tumors of Digestive System

Digestive Tumor
Shanghai NewMed Medical Co., Ltd.
Shanghai Phigine Medical Technology Co., Ltd.

Not yet recruiting

Phitys I™ Percutaneous Left Ventricular Assist System Study

Coronary Artery Disease

China
Seoul National University Hospital
Dong-A PharmTech Co., Ltd.

Completed

The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension | Dyspnea

Korea, Republic of
Oneness Biotech Co., Ltd.
Microbio Shanghai Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

Allergic Asthma

Taiwan
Wuhan BravoVax Co., Ltd.
Shanghai BravoBio Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine

Herpes Zoster
Shanghai iCELL Biotechnology Co., Ltd, Shanghai...

Not yet recruiting

Safety and Efficacy Study of hAESCs Therapy for aGVHD (aGVHD，hAESCs)

GVHD,Acute
Shanghai Yidian Pharmaceutical Technology Development...

Recruiting

HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer

Recurrent Extensive Stage Small Cell Lung Carcinoma

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma

Indolent B-cell Lymphoma
Shanghai Shengdi Pharmaceutical Co., Ltd

Recruiting

A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer

Locally Advanced Cervical Cancer

China
Shanghai Yuyao Biotech Co., Ltd.

Recruiting

An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies

Advanced Solid Tumor | Hematological Malignancy

China
Shanghai Vitalgen BioPharma Co., Ltd.

Not yet recruiting

A Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b

Glutaric Acidemia Type I | Glutaric Aciduria Type I

China
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Not yet recruiting

Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis

Atopic Dermatitis

China

Clinical Trials Sponsored by Shanghai Jiatan Pharmatech Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations